ESC Highlights

Charalambos Antoniades, ESC 2021 – The Fat Attenuation Index

Prof. Charalambos Antoniades (Professor of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK) kindly shared his thoughts on the fat attenuation index and its use in clinical decision making from the virtual ESC Congress 2021. Questions Can you tell us a little about the fat attenuation index (FAI) and how it can be […]

Atherosclerosis

Charalambos Antoniades, ESC 2021 – High-sensitivity C-reactive Protein, Perivascular Adipose Tissue and Atherosclerosis

Watch Time: 2 mins 32

Prof. Charalambos Antoniades (Professor of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK) kindly shared his thoughts on the use of high-sensitivity C-reactive protein as a biomarker in clinical decision making, and the role of perivascular adipose tissue in the pathogenesis of atherosclerosis from the virtual ESC Congress 2021. Questions What is the […]

Hypertension

Clara Chow, ESC 2021 – the QUARTET Study

Watch Time: 8 mins 10

Dr Clara Chow (Professor of Medicine, Academic Director Westmead Applied Research Centre, University of Sydney, Sydney, Australia) kindly shared her thoughts on the limitations of current treatment paradigms for hypertension, the quad pill for hypertension, and the QUARTET study, from the virtual ESC Congress 2021. Questions What are the limitations of current treatment paradigms for […]

Interventional Cardiology

Peter Smits, ESC 2021 – High Bleeding Risk After Coronary Stenting

Watch Time: 7 mins 24

Dr Peter Smits (Interventional Cardiologist, Maasstad Hospital, Rotterdam, The Netherlands) kindly shared his thoughts on the major challenges in the treatment of patients at high bleeding risk after coronary stenting, with an overview of the recent key clinical trials involving percutaneous coronary intervention with stent deployment in patients at high bleeding risk, from the virtual ESC […]

Heart Failure, Myocardial Infarction

Roxana Mehran, ESC 2021 – the PARADISE-MI Trial

Watch Time: 9 mins 52

Dr Roxana Mehran (Director of Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine, Mount Sinai Hospital, New York City, NY, USA) kindly shared her thoughts on the the PARADISE-MI trial (NCT02924727) from from the virtual ESC Congress 2021. Questions What has been the impact of angiotensin receptor-neprilysin inhibitors (ARNIs) on the treatment of […]

Atherosclerosis, Cardiovascular Disease

Stephen Nicholls, ESC 2021 – the HUYGENS Study

Watch Time: 6 mins 20

Prof. Stephen Nicholls (Professor of Cardiology, Monash University, Melbourne, Australia) kindly shared his thoughts on the impact of PCSK9 inhibitors on lipid-lowering therapy, the effects of statins on coronary atherosclerotic plaques and the HUYGENS study from the virtual ESC Congress 2021. Questions What has been the impact of PCSK9 inhibitors on lipid-lowering therapy, and what […]

Cardiovascular Disease

Jordan Strom, ESC 2021 – Analysis of the Risks of Moderate and Lesser Aortic Stenosis

Watch Time: 14 mins

Dr Jordan Strom (Director of Echocardiographic Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) kindly shared his thoughts on his recent analysis of clinical trial and administrative claims data on patients with untreated aortic stenosis from the virtual ESC Congress 2021. Questions What are the aims and scope of your current […]

Cardiovascular Disease

Jordan Strom, ESC 2021 – Untreated Aortic Stenosis

Watch Time: 4 mins 9

Dr Jordan Strom (Director of Echocardiographic Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) kindly shared his thoughts on the prognosis of people with untreated aortic stenosis from the virtual ESC Congress 2021. Questions What is known about the prognosis of people with untreated aortic stenosis? (0.29) How have advances in […]

Cardiovascular Disease, Hypertension

Kazem Rahimi, ESC 2021 – the Blood Pressure Lowering Treatment Trialists Collaboration

Watch Time: 3 mins 30

Dr Kazem Rahimi (Professor of Cardiovascular Medicine and Population Health, University of Oxford, Oxford, UK) kindly shared his thoughts on the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC), its aims, and the benefits of antihypertensive medicines in older people from the virtual ESC Congress 2021. Questions Could you tell us a little about the Blood […]

FILTER YOUR SEARCH

Speciality: